Form DEFA14A Fortress Biotech, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- S&P 500, Nasdaq decline as Iran tensions jolt sentiment; chip stocks fall
- SK Hynix’s record plunge drags down global chip stocks
- Oil gains over 4% as Trump says US reinstating Iran naval blockade
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- S&P 500, Nasdaq decline as Iran tensions jolt sentiment; chip stocks fall
- Japan has no plans to overhaul pension funds' asset allocation, sources say
Fortress Biotech (FBIO) PT Raised to $24 at H.C. Wainwright
April 9, 2024 6:07 AM EDTH.C. Wainwright analyst Joseph Pantginis raised the price target on Fortress Biotech (NASDAQ: FBIO) to $24.00 (from $10.00) while maintaining a Buy rating.
The analyst comments "We are taking this opportunity to: (1) highlight significant upcoming regulatory milestones for Fortress partners, and; (2) bring attention to a significant... More
